Definitive Contract 75A50123C00041

Award Date 9/22/23
Potential Completion Date 10/31/25
Potential Value $728K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Isle of Man
Solicitation Procedures
Basic Research
Number Of Offers Received
99
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $749,549.00, was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Immunexpress Inc., a for-profit foreign-owned company. The contract is for the "ASSESSMENT & TRIAGE OF PATIENTS WITH ESCALATING SIGNS OF COVID-19 DISEASE USING A HOST RESPONSE TEST FOR SEPSIS" and is a definitive, firm-fixed-price contract with a period of performance ending on June 10, 2023. The contract award originated from a Broad...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, for the development of a "Point of Care Host-Pathogen Monitoring System." The fixed-price contract has a ceiling value of $149,503.39 and was awarded on November 18, 2016, with a completion date of November 27, 2017. Mbio Diagnostics Inc. is a for-profit organization that develops...
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Pattern Bioscience, Inc., a biotechnology company, to develop a rapid pathogen identification and antimicrobial susceptibility testing platform. The contract, valued at $40,937,536.73, is for the verification, clinical evaluation, and U.S. Food and Drug Administration (FDA) clearance of this culture-free, phenotypic diagnostic platform. The contract is a...
This federal contract award, valued at $285,942.75, was issued by the Joint PEO Chemical and Biological Defense program of the U.S. Department of Defense to the small disadvantaged business Biomeme, Inc. The contract is for the development of a YP (Yersinia pestis) assay, which is a diagnostic test for detecting the bacteria that causes plague. This delivery order contract has a firm fixed price pricing type and a completion date of March 30, 2016. Biomeme, a manufacturer of innovative molecular...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency Troop Support Medical to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $9,520.00 and an ultimate completion date of July 5, 2024. The contract is for the provision of XPCOV2/FLU/RSV-10 diagnostic tests, which are used to detect COVID-19, influenza, and respiratory syncytial virus. Cepheid has a history of federal contract awards, including indefinite...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Medical Supply Chain division of the Defense Logistics Agency. The $2,720.00 firm fixed-price delivery order contract is for Cepheid to provide GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has no set-aside designation. In...
This is a delivery order contract awarded to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency Troop Support Medical (DLATSMED-A), a component of the Department of Defense. The $6,800.00 firm fixed price contract is for the provision of XPCOV2/FLU/RSV-10 diagnostic tests, which are used to detect COVID-19, influenza, and respiratory syncytial virus. The contract has an ultimate completion date of April 1, 2024. Cepheid is the prime contractor...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, with a ceiling value of $13,600.00, is a delivery order for XPCOV2/FLU/RSV-10 tests, which are used to detect COVID-19, influenza, and respiratory syncytial virus. The contract has an ultimate completion date of January 10, 2025 and does not have a set-aside designation. Cepheid is the prime contractor and original...
This is a $52,239,640.00 definitive contract awarded to Visby Medical, Inc. by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. The contract is for the delivery of a rapid, accurate, point-of-care disposable influenza and SARS-CoV-2 molecular diagnostic test. This award is not set aside for any particular business classification. The contract has an ultimate completion date of March 31, 2026. The original solicitation was issued...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is for the delivery of XPCOV2/FLU/RSV-10 products, which are likely diagnostic test kits for COVID-19, influenza, and respiratory syncytial virus (RSV). The contract is a firm fixed-price delivery order with a ceiling value of $14,448.00 and a performance period ending on April 30, 2025. Cepheid is a prime contractor that has been...

This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Memed Diagnostics LTD, a for-profit limited liability company based in Israel. The contract is for an R&D effort to demonstrate the clinical utility of Memed's rapid host-based diagnostic (HBD) for distinguishing bacterial versus viral infection, under the MEMED DIAGNOSTICS major program. The contract has a firm fixed price of $727,799.32 and a completion date of October 31, 2025. No set-aside was used for this award.

Generated 5/23/25, 10:09 AM